Welcome



Welcome to our updated website. Building on the outstanding success of the CSF we are evolving our services across the wider range of immune medicated inflammatory diseases with our new site. Don't forget to bookmark this page!

Over the coming months we will add in new disease areas and you will be able to choose and filter the content that is of most interest to you. For now we have updated our website to allow us to expand and you will see some new layouts and features. Please explore and let us know what you think.

Our offering has not changed: we provide unique educational materials, all for free. Thank you once again for your continued support and feedback across the years. We hope you enjoy the new website.

The Immune Mediated Inflammatory Disease Forum Team


About the Immune-Mediated Inflammatory Disease Forum

Rare Disease Day 2024

ACR 2023 - CSF coverage highlights the most relevant data on RA, PsA, and axSpA. Including our Preview Brochures highlighting key posters and oral presentations ahead of the congress.

Baricitinib in Juvenile Idiopathic Arthritis: An International, Phase 3, Randomised, Double-blind, Placebo-controlled, Withdrawal, Efficacy, and Safety Trial

EULAR 2023 - CSF coverage highlights the most relevant data on RA, PsA, and axSpA. Including our Preview Brochures highlighting key posters and oral presentations ahead of the congress.

Steering Committee